Skip to content

Clinical trials

Phase 2 Cancer Pain trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cancer Pain Phase: Phase 2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20081
20092
20121
20191
20201
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting3
Terminated2
Recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center3
M.D. Anderson Cancer Center2
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Dogwood Therapeutics Inc.1
Janssen Research & Development, LLC1
National Institutes of Health Clinical Center (CC)1
Pfizer1
Sorrento Therapeutics, Inc.1
Tetra Bio-Pharma1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cancer Pain13
Pain7
Neoplasms3
Acute Pain1
Arthralgia1
Breast Neoplasms1
Chronic Pain1
Colorectal Neoplasms1
Constipation1
Intestinal Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.